Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

KLX Inc (KLXI): Farallon Capital Discloses New Stake in B/E Aerospace Inc (BEAV)’s Spin-Off

Farallon Capital, a fund launched by Thomas Steyer in 1986, has recently added KLX Inc (NASDAQ:KLXI) to its equity portfolio. According to a new filing with the Securities and Exchange Commission, Farallon currently owns some 3.68 million shares of the company. The stake is passive by nature and amasses 7.0% of KLX’s outstanding common stock.


With an equity portfolio of over $6 billion, Farallon is a fund that was founded by Thomas Steyer, a former financial analyst at Morgan Stanley’s mergers and acquisitions department. Even though the fund has a diversified equity portfolio, it invests primarily in Services, Technology and Financial stocks. At the end of September, two largest holdings in Farallon’s equity portfolio were represented by  DIRECTV (NASDAQ:DTV) and Covidien plc (NYSE:COV). Both stakes amassed around 5% of the fund’s total portfolio and have been initiated during the second quarter and raised significantly during the July-September period. While DIRECTV, of which Farallon owned 3.65 million shares (up by 288% on the quarter) appreciated only slightly since the second quarter of 2014, Covidien jumped by 56% on the back of its acquisition by Medtronic, Inc. (NYSE:MDT) that was completed on January 26, while Farallon held 3.64 million shares at the end of September.

In its previous filing, Farallon disclosed entering into a lock-up agreement with Hudson Pacific Properties Inc (NYSE:HPP), of which it owns 8.74 million shares. Under the terms of the agreement, Farallon, which holds an activist stake equal to 10.9% of the company, agreed not to sell any shares of the company for the next 60 days.

Farallon’s latest acquisition, KLX Inc (NASDAQ:KLXI), is a company that has been publicly traded for a bit over a month now, after it was spun off from B/E Aerospace Inc (NASDAQ:BEAV). KLX operates in two segments, Aerospace Solutions Group and Energy Services Group and is engaged in distribution and servicing of aerospace fasteners and consumables. Since it went public, the company that has a market cap of $2.0 billion, lost around 19%.

B/E Aerospace Inc (NASDAQ:BEAV) conducted the spin-off via a dividend distribution of all KLX Inc (NASDAQ:KLXI) stock to the shareholders of B/E Aerospace, under the terms of which each shareholder received one KLX share for every two shares of B/E Aerospace Inc (NASDAQ:BEAV). The decision to spin-off the consumables division of B/E will allow the companies to benefit from a better management focus and will provide more value to shareholders.

KLX Inc (NASDAQ:KLXI) is yet to disclose its financial results for the first quarter since becoming an independent company, but as for now analysts are not very thrilled about the stock, which has a consensus ‘Hold’ rating. Earlier this year, Deutsche Bank lowered price target on the stock to $46.00 from $48.00 reiterating ‘Hold’ rating, while RBC Capital initiated coverage with ‘Sector Perform’ rating. On the other hand, a couple of weeks ago, KeyCorp upgraded the stock to ‘Buy’ from ‘Hold’.

Among other shareholders of KLX Inc (NASDAQ:KLXI) is Daniel S. Och‘s OZ Management, which revealed holding around 2.90 million shares, equal to 5.51% of the company’s stock, right after the company went public. OZ Management also disclosed holding 5.67 million shares of B/E Aerospace Inc (NASDAQ:BEAV) in its latest 13F filing. On the insiders side, at the end of 2014, Heather Floyd, the vice-president of finance and controller of KLX Inc (NASDAQ:KLXI), sold 123 shares of the company at $41.15 per unit, trimming its stake to 5,395 shares.

Disclosure: none

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!